alloxan has been researched along with 1,4-naphthoquinone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
Barreto, E; Cardoso, SH; de Carvalho Correia, AC; de Oliveira Dos Santos Carmo, J; de Oliveira, CR; de Souza Ferro, JN; GuimarĂ£es, AS; Nascimento, J | 1 |
2 other study(ies) available for alloxan and 1,4-naphthoquinone
Article | Year |
---|---|
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |
Synthesis of newly functionalized 1,4-naphthoquinone derivatives and their effects on wound healing in alloxan-induced diabetic mice.
Topics: 3T3 Cells; Administration, Topical; Alloxan; Animals; Carbon-13 Magnetic Resonance Spectroscopy; Cell Movement; Cell Survival; Diabetes Mellitus, Experimental; Fibroblasts; Male; Mice; Naphthoquinones; Proton Magnetic Resonance Spectroscopy; Spectroscopy, Fourier Transform Infrared; Wound Healing | 2018 |